Pulmonary Medicine
Cardiovascular Medicine
Infectious Disease
Nephrology
Gastroenterology
100

Initial imaging for CTEPH

V/Q scan

100

Treatment for AF with rapid heart rate and hemodynamic instability

Cardioversion

100

Adjunctive bacterial meningitis treatment

Dexamethasone

100

Immediate treatment of severe hyperkalemia

IV calcium gluconate and insulin (with or without glucose)

100

Gold standard diagnostic test for achalasia

Esophageal manometry

200

Treatment for vasoreactive-positive PAH

CCB

200

HF indications for ICD placement

LVEF ≤35%, NYHA functional class II-III symptoms

200

Empiric antibiotics for bacterial meningitis, age >50 years

Ampicillin plus ceftriaxone plus vancomycin

200

Treatment of anti-GBM antibody disease

Plasmapheresis, glucocorticoids, cyclophosphamide

200

Treatment for Barrett esophagus with dysplasia

Endoscopic mucosal resection, followed by radiofrequency ablation or cryotherapy

300

Treatment for CTEPH

Pulmonary thromboendarterectomy and anticoagulation

300

Drug that lowers mortality and HF hospitalization 20% compared with enalapril in patients with symptomatic HFrEF

Valsartan-sacubitril

300

Preferred HIV ART regimen for most patients

Three-drug regimen from two different classes, preferably including an integrase inhibitor

300

Hepatorenal syndrome treatment

Stop diuretics; start albumin; start terlipressin or midodrine and octreotide

300

Primary variceal bleeding treatment

Octreotide, somatostatin, or terlipressin; endoscopic therapy

400

Systemic sclerosis variant associated with PAH

Limited cutaneous systemic sclerosis

400

Treatment of recurrent symptomatic AF

Catheter ablation with pulmonary vein isolation

400

Management of rhino-orbital-cerebral mucormycosis

Extensive surgical debridement and early antifungal therapy

400

Medication for persistent albuminuria despite maximum RAS inhibition in DKD

Finerenone

400

Preferred induction treatment for ulcerative colitis unresponsive to 5-ASA

Infliximab

500

First-line therapy for PAH if tolerated

Endothelin-1 receptor antagonist plus PDE-5 inhibitor

500

Disease-specific therapy for transthyretin amyloid cardiac amyloidosis

Tafamidis, acoramidis, vutrisiran

500

Empiric treatment for TB meningitis

4-drug anti-TB regimen of rifampin, isoniazid, pyrazinamide, and ethambutol plus dexamethasone

500

Causes of increased anion gap metabolic acidosis with high osmolal gap

Methanol, ethylene glycol, or propylene glycol

500

Management of diarrhea and colitis caused by immune checkpoint inhibitors

Medication discontinuation; glucocorticoids or biologic therapy

M
e
n
u